Skip to main content

Table 2 univariate analysis for LC, FFHF and OS

From: Stereotactic body radiation therapy (SBRT) in patients with hepatocellular carcinoma and oligometastatic liver disease

 

LC

FFHF

OS

 

1-year rate

p value

1-year rate

p value

1-year rate

p value

gender

male

88%

0.279

44%

0.679

83%

0.055

female

94%

41%

67%

age

≤ median (64 yrs)

92%

0.265

40%

0.687

77%

0.76

> median

90%

43%

75%

histology

HCC

92%

0.492

41%

0.895

68%

0.701

MD

89%

40%

84%

KPS

≤70

100%

0.425

42%

0.579

50%

0.028

> 70

90%

42%

79%

GTV

≤ median (14.6 ccm)

100%

0.535

46%

0.794

80%

0.416

> median

88%

44%

77%

BED

≤ 100

87%

0.651

38%

0.419

75%

0.806

>  100

94%

48%

77%

lesions

single

97%

0.011

49%

0.047

80%

< 0.001

multiple

67%

19%

40%

  1. LC: Local control, FFHF: Freedom from hepatic failure, OS: Overall survival, yrs.: years, HCC: hepatocellular carcinoma, MD: metastastic disease, KPS: Karnofsky performance score, GTV: Gross tumor volume (measured per patient on free-breathing CT), ccm: cubic centimeters, BED: biological equivalent dose